Kyntra Bio (KYNB) Net Margin (2014 - 2026)
Kyntra Bio's (KYNB) quarterly Net Margin came in at 812.35% in Q2 2026, up 137637.0% year-over-year from N/an in Q2 2025, and up 299.8% quarter-over-quarter from 406.58% in Q1 2026.
Powered by 
Analysis
Kyntra Bio (KYNB) Net Margin (2014 - 2026) Analysis & Trends
Kyntra Bio has disclosed Net Margin across 13 years of filings, most recently posting 812.35% for Q2 2026.
- In Q2 2026, Net Margin rose 137637.0% year-over-year to 812.35%; the TTM figure through Jun 2026 stood at 2582.21% (up 261034.0% YoY), while the FY2025 annual figure was 3037.33%, up 319796.0% from the prior year.
- Net Margin came in at 812.35% for Q2 2026 at Kyntra Bio, up from 406.58% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 18646.47% in Q3 2025 to a low of 13889.43% in Q3 2024.
- Average Net Margin over 5 years is 73.26%, with a median of 180.51% recorded in 2025.
- Year-over-year, Net Margin plunged 1372924 bps in 2024 and jumped 3253590 bps in 2025.
- Over 5 years, Net Margin stood at 791.13% in 2022, then soared by 116 bps to 125.93% in 2023, then surged by 355 bps to 573.59% in 2024, then sank by 128 bps to 161.94% in 2025, then jumped by 602 bps to 812.35% in 2026.
- Per Business Quant data, the three most recent Net Margin figures were 812.35% in Q2 2026, 406.58% in Q1 2026, and 161.94% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.78 Bn | 192.79 Bn | 7.24 Bn | 23.62% |
| 2 | Gilead Sciences | 179.92 Bn | 176.74 Bn | 6.22 Bn | -134.51% |
| 3 | Vertex Pharmaceuticals | 131.39 Bn | 123.54 Bn | 2.84 Bn | 32.99% |
| 4 | Regeneron Pharmaceuticals | 81.91 Bn | 73.91 Bn | 3.93 Bn | 30.23% |
| 5 | Argenx Se | 60.35 Bn | 55.17 Bn | 1.37 Bn | 31.16% |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn | -539.31% |
| 7 | Alnylam Pharmaceuticals | 33.12 Bn | 29.81 Bn | 992.69 Mn | 12.74% |
| 8 | Biogen | 31.92 Bn | 30.63 Bn | 1.96 Bn | 3.56% |
| 9 | Roivant Sciences | 29.23 Bn | 29.23 Bn | 1.16 Mn | -20,152.98% |
| 10 | Kyntra Bio | 32.08 Mn | 32.08 Mn | 1.47 Mn | 812.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 812.35% |
| Mar 31, 2026 | -406.58% |
| Dec 31, 2025 | -161.94% |
| Sep 30, 2025 | 18,646.47% |
| Jun 30, 2025 | -564.02% |
| Mar 31, 2025 | 169.37% |
| Dec 31, 2024 | 573.59% |
| Sep 30, 2024 | -13,889.43% |
| Jun 30, 2024 | -1,557.52% |
| Mar 31, 2024 | -129.84% |
| Dec 31, 2023 | 125.93% |
| Sep 30, 2023 | -160.19% |
| Jun 30, 2023 | -199.08% |
| Mar 31, 2023 | -214.32% |
| Dec 31, 2022 | -791.13% |
| Sep 30, 2022 | -585.05% |
| Jun 30, 2022 | -245.55% |
| Mar 31, 2022 | -104.44% |
| Dec 31, 2021 | -812.56% |
| Sep 30, 2021 | 31.71% |